United States · FDA National Drug Code directory
Atovaquone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42239-001_34f67d35-7080-d493-e063-6294a90a5cc9
- Product NDC
- 42239-001
- Form
- SUSPENSION
- Composition / generic term
- Atovaquone
- Labeler
- Abon Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231114
- Source listing expiry
- 20261231
Source-listed ingredients
- ATOVAQUONE — 750 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (42239-001-08) / 210 mL in 1 BOTTLE · 42239-001-08
- 6 CUP, UNIT-DOSE in 1 TRAY (42239-001-66) / 5 mL in 1 CUP, UNIT-DOSE (42239-001-17) · 42239-001-66
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →